Get the Stockscreener App
46.28
1.07%
0.49
After Hours:
46.18
-0.10
-0.22%
Spdr Pharmaceuticals Etf stock is traded at $46.28, with a volume of 14,300.
It is up +1.07% in the last 24 hours and up +1.34% over the past month.
See More
Previous Close:
$45.79
Open:
$45.91
24h Volume:
14,300
Relative Volume:
0.28
Market Cap:
$229.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.69%
1M Performance:
+1.34%
6M Performance:
+15.07%
1Y Performance:
+25.45%
1-Day Range:
$45.91
$46.44
1-Week Range:
$45.43
$46.70
52-Week Range:
$36.49
$48.76
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Name
Spdr Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
46.28 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
298.20 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
598.83 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
601.82 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
259.72 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
505.30 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Stock (XPH) Latest News
XBI: 3 Biotech ETFs for Diversified Innovation Exposure - StockNews.com
Objective long/short (XPH) Report - Stock Traders Daily
Here's Why a Handful of Pharmaceutical Stocks Rose Wednesday - MSN
Top 5 Life Science ETFs in 2024 - Investing News Network
Pharma stocks fall as Trump picks vaccine skeptic Robert F. Kennedy Jr. for US health job - USA TODAY
What Are Wall Street Analysts' Target Price for Zoetis Stock? - Inkl
Global Pharma carries the most overweight allocations in Nov – according to BofA’s Global FMS - MSN
(XPH) Long Term Investment Analysis - Stock Traders Daily
Barrick Gold Corp (GOLD-N) QuotePress Release - The Globe and Mail
Boeing Company (BA-N) QuotePress Release - The Globe and Mail
Johnson & Johnson (JNJ-N) QuotePress Release - The Globe and Mail
Are Wall Street Analysts Predicting Viatris Stock Will Climb or Sink? - MSN
Exxon Mobil Corp (XOM-N) QuotePress Release - The Globe and Mail
5 Biggest Pharmaceutical ETFs in 2024 - Investing News Network
7 Best-Performing Biotech ETFs for November 2024 - NerdWallet
Select Sector SPDR ETFs Offer Targeted Investment Opportunities Across Economic Sectors - Citybuzz
Should You Invest in the Financial Select Sector SPDR ETF (XLF)? - Yahoo Finance
(XPH) Investment Analysis and Advice - Stock Traders Daily
Best Biotech ETFs to Watch Right Now - The Motley Fool
XLV: 3 Healthcare ETFs to Buy for Defensive Growth - StockNews.com
Healthcare bankruptcies slow after peaking in 2023: report - MSN
Here's exactly how to prepare for a Trump or Harris presidency — and how to build a 5-part 'election-proof portfolio' - Business Insider
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike - MSN
What's the State of the Market? We'll Let the Charts Do the Talking - TheStreet
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)? - MSN
The Technology Select Sector SPDR Fund (XLK) Stock Price, News, Quote & History - Yahoo Finance
How to Take Advantage of moves in (XPH) - Stock Traders Daily
6 Best Health Care ETFs to Buy Now | Investing - U.S News & World Report Money
Commonwealth Equity Services LLC Acquires 602 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Hancock Whitney Corp Acquires 1,440 Shares of SPDR S&P Emerging Markets SmallCap ETF (NYSEARCA:EWX) - Defense World
The Energy Select Sector SPDR Fund (XLE) Stock Price, News, Quote & History - Yahoo Finance
Trend Tracker for (XPH) - Stock Traders Daily
Ashton Thomas Private Wealth LLC Makes New Investment in SPDR MSCI ACWI ex-US ETF (NYSEARCA:CWI) - Defense World
Healthcare Stocks Have Popped. Consider These 2 That Haven’t. - Barron's
XLV: 3 Healthcare ETFs to Buy for Broad Sector Exposure - StockNews.com
A State Street Fund Excels in Rough Year for Healthcare Stocks - Kiplinger's Personal Finance
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
SPDR Bloomberg High Yield Bond ETF (NYSEARCA:JNK) Shares Sold by Wealth Enhancement Advisory Services LLC - Defense World
Comerica Bank Sells 2,311 Shares of SPDR Bloomberg 3-12 Month T-Bill ETF (NYSEARCA:BILS) - Defense World
Envestnet Portfolio Solutions Inc. Acquires 1,510 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
IBB: 3 Biotech ETFs for a Diversified Portfolio - StockNews.com
Pharma ETFs in Focus Post Solid Q2 Earnings - Yahoo Finance
Disruptive Theme of the Week: Playing Defense - ETFdb.com
SPDR Portfolio S&P 1500 Composite Stock Market ETF (NYSEARCA:SPTM) Stock Price Up 1.6% - Defense World
TSX 60 Shariah Index (TXSI) QuotePress Release - The Globe and Mail
268 Shares in SPDR S&P Dividend ETF (NYSEARCA:SDY) Bought by Opal Wealth Advisors LLC - Defense World
Price T Rowe Associates Inc. MD Purchases 920 Shares of SPDR S&P MidCap 400 ETF Trust (NYSEARCA:MDY) - Defense World
2 Biotech Stocks to Buy Hand Over Fist in August - AOL
Cetera Advisors LLC Has $953,000 Stock Position in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
SPDR Portfolio S&P 600 Small Cap ETF (NYSEARCA:SPSM) Shares Purchased by GAMMA Investing LLC - Defense World
SPDR S&P 400 Mid CapGrowth ETF (NYSEARCA:MDYG) Shares Sold by Park Avenue Securities LLC - Defense World
Spdr Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for Spdr Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.04%
0.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):